CONTEXTVISION AB (CONTX.OL) Stock Fundamental Analysis
OSL:CONTX - Euronext Oslo - SE0014731154 - Common Stock - Currency: NOK
Overall CONTX gets a fundamental rating of 7 out of 10. We evaluated CONTX against 11 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making CONTX a very profitable company, without any liquidiy or solvency issues. CONTX is valued quite cheap, while showing a decent growth score. This is a good combination! These ratings would make CONTX suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year CONTX was profitable.
CONTX had a positive operating cash flow in the past year.
CONTX had positive earnings in 4 of the past 5 years.
In the past 5 years CONTX always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 10.31%, CONTX belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
CONTX's Return On Equity of 14.29% is amongst the best of the industry. CONTX outperforms 81.82% of its industry peers.
CONTX has a better Return On Invested Capital (12.59%) than 100.00% of its industry peers.
CONTX had an Average Return On Invested Capital over the past 3 years of 36.72%. This is significantly above the industry average of 7.26%.
The 3 year average ROIC (36.72%) for CONTX is well above the current ROIC(12.59%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROIC | 12.59% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
1.3 Margins
Looking at the Profit Margin, with a value of 10.66%, CONTX is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
In the last couple of years the Profit Margin of CONTX has grown nicely.
CONTX's Operating Margin of 12.82% is amongst the best of the industry. CONTX outperforms 81.82% of its industry peers.
CONTX's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 97.41%, CONTX belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
CONTX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% |
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CONTX is creating value.
Compared to 1 year ago, CONTX has about the same amount of shares outstanding.
CONTX has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, CONTX has a worse debt to assets ratio.
2.2 Solvency
CONTX has a debt to FCF ratio of 0.50. This is a very positive value and a sign of high solvency as it would only need 0.50 years to pay back of all of its debts.
CONTX's Debt to FCF ratio of 0.50 is amongst the best of the industry. CONTX outperforms 90.91% of its industry peers.
CONTX has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
CONTX has a Debt to Equity ratio of 0.08. This is amongst the best in the industry. CONTX outperforms 81.82% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Altman-Z | N/A |
ROIC/WACC1.81
WACC6.95%
2.3 Liquidity
CONTX has a Current Ratio of 3.66. This indicates that CONTX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.66, CONTX belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 3.59 indicates that CONTX has no problem at all paying its short term obligations.
The Quick ratio of CONTX (3.59) is better than 100.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 |
3. Growth
3.1 Past
The earnings per share for CONTX have decreased strongly by -60.55% in the last year.
The Earnings Per Share has been growing by 27.26% on average over the past years. This is a very strong growth
The Revenue has decreased by -9.00% in the past year.
The Revenue has been growing slightly by 6.51% on average over the past years.
EPS 1Y (TTM)-60.55%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-136.36%
Revenue 1Y (TTM)-9%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-24.22%
3.2 Future
CONTX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.49% yearly.
The Revenue is expected to grow by 5.99% on average over the next years.
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue Next Year-3.12%
Revenue Next 2Y0.39%
Revenue Next 3Y3.28%
Revenue Next 5Y5.99%
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 27.22, CONTX can be considered very expensive at the moment.
72.73% of the companies in the same industry are more expensive than CONTX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.25, CONTX is valued at the same level.
The Price/Forward Earnings ratio is 10.00, which indicates a very decent valuation of CONTX.
90.91% of the companies in the same industry are more expensive than CONTX, based on the Price/Forward Earnings ratio.
CONTX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.22 | ||
| Fwd PE | 10 |
4.2 Price Multiples
CONTX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. CONTX is cheaper than 63.64% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, CONTX is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.67 | ||
| EV/EBITDA | 12.03 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CONTX has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as CONTX's earnings are expected to grow with 21.49% in the coming years.
PEG (NY)0.66
PEG (5Y)1
EPS Next 2Y24.57%
EPS Next 3Y21.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 4.18%, CONTX is a good candidate for dividend investing.
The stock price of CONTX dropped by -20.06% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.69, CONTX pays a bit more dividend than its industry peers.
CONTX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
OSL:CONTX (5/30/2025, 7:00:00 PM)
4.9
+0.09 (+1.87%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners15.98%
Inst Owner ChangeN/A
Ins Owners25.32%
Ins Owner ChangeN/A
Market Cap379.11M
Analysts84.44
Price Target7.14 (45.71%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.18% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)16.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)46.43%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-9.49%
Revenue NY rev (3m)-6.77%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.22 | ||
| Fwd PE | 10 | ||
| P/S | 2.93 | ||
| P/FCF | 18.67 | ||
| P/OCF | 13.74 | ||
| P/B | 3.94 | ||
| P/tB | 4.08 | ||
| EV/EBITDA | 12.03 |
EPS(TTM)0.18
EY3.67%
EPS(NY)0.49
Fwd EY10%
FCF(TTM)0.26
FCFY5.36%
OCF(TTM)0.36
OCFY7.28%
SpS1.67
BVpS1.25
TBVpS1.2
PEG (NY)0.66
PEG (5Y)1
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.31% | ||
| ROE | 14.29% | ||
| ROCE | 15.94% | ||
| ROIC | 12.59% | ||
| ROICexc | 44.69% | ||
| ROICexgc | 50.4% | ||
| OM | 12.82% | ||
| PM (TTM) | 10.66% | ||
| GM | 97.41% | ||
| FCFM | 15.71% |
ROA(3y)26.09%
ROA(5y)16.55%
ROE(3y)37.17%
ROE(5y)21.28%
ROIC(3y)36.72%
ROIC(5y)47.42%
ROICexc(3y)120.16%
ROICexc(5y)134.4%
ROICexgc(3y)169.64%
ROICexgc(5y)243.25%
ROCE(3y)46.47%
ROCE(5y)60.03%
ROICexcg growth 3Y-39.35%
ROICexcg growth 5Y-1.08%
ROICexc growth 3Y-26.11%
ROICexc growth 5Y14.23%
OM growth 3Y-20.47%
OM growth 5Y1.61%
PM growth 3YN/A
PM growth 5Y19.46%
GM growth 3Y-0.19%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.97
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.5 | ||
| Debt/EBITDA | 0.29 | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 107.84% | ||
| Profit Quality | 147.45% | ||
| Current Ratio | 3.66 | ||
| Quick Ratio | 3.59 | ||
| Altman-Z | N/A |
F-Score4
WACC6.95%
ROIC/WACC1.81
Cap/Depr(3y)55.3%
Cap/Depr(5y)58.55%
Cap/Sales(3y)3.81%
Cap/Sales(5y)5.04%
Profit Quality(3y)103.4%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-60.55%
EPS 3YN/A
EPS 5Y27.26%
EPS Q2Q%-136.36%
EPS Next Y41.38%
EPS Next 2Y24.57%
EPS Next 3Y21.49%
EPS Next 5YN/A
Revenue 1Y (TTM)-9%
Revenue growth 3Y10.03%
Revenue growth 5Y6.51%
Sales Q2Q%-24.22%
Revenue Next Year-3.12%
Revenue Next 2Y0.39%
Revenue Next 3Y3.28%
Revenue Next 5Y5.99%
EBIT growth 1Y-60.97%
EBIT growth 3Y-12.49%
EBIT growth 5Y8.23%
EBIT Next Year-3.57%
EBIT Next 3Y20.51%
EBIT Next 5YN/A
FCF growth 1Y-35.26%
FCF growth 3Y82.69%
FCF growth 5Y67.13%
OCF growth 1Y-34.27%
OCF growth 3Y51.49%
OCF growth 5Y5.6%